0       0


ST1-9: Bioprinting: Translational Pathway to the Clinic (AABB/TERMIS-AM Joint Session)


Oct 19, 2019 8:00am ‐ Oct 19, 2019 9:30am

Description

Bioprinting has become an innovative tool for tissue engineering and regenerative medicine. This technology has been developed to allow construction of biological substitutes mimicking structures and functions of native tissues or organs. 3D Bioprinting enables precise placement of various cell types, biomaterials, and bioactive molecules in a single three-dimensional (3-D) architecture. This session will provide insights into the rapidly developing area of bioprinting and how this technology is being developed for clinical applications as well as the regulatory considerations.

Learning Objectives:

  • Discuss the fundamentals of Biofabrication.
  • Discuss the current status of regulatory oversight.
  • Describe how bioprinting technology is translated into the clinic.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content